June 20, 2018We are seeking a full time Quality Assurance Associate to work in our Gaithersburg office. This is an exciting opportunity to join and grow with our team to contribute and share in our company vision: A day when methods based on humane, wisely applied science will be used by industry and the regulatory agencies to understand the true safety and efficacy of substances.
The Quality Assurance Associate is asked to participate in the Quality Assurance monitoring and Good Laboratory Practice auditing...
June 8, 2018We are seeking a full time Client Services Representative to work in our Gaithersburg office. This is an exciting opportunity to join and grow with our team to contribute and share in our company vision: A day when methods based on humane, wisely applied science will be used by industry and the regulatory agencies to understand the true safety and efficacy of substances.
Looking for a highly motivated, organized, and detail oriented person to serve as primary liaison between the Institute...
June 7, 2018IIVS President, Erin Hill, and Business Development Manager, Brent Gilbert, will be at the upcoming EuroTox 2018 in Brussels on September 3-5. Stop by our booth (#55) to chat with us or contact us to set up a meeting.
In addition, IIVS will be presenting two posters. Text to be added.
...
June 1, 2018Yesterday, the California Senate passed the California Cruelty-Free Cosmetics Act (SB1249) bringing the state one step closer to becoming the first state in the U.S. to ban the sale of animal-tested cosmetics.
The bill will now move on to the Assembly. If passed, SB1249 will outlaw the sale of all animal-tested cosmetics (including makeup, hair and skin care, and personal hygiene products) by 2020.
Read more....
May 30, 2018Our very own Holger Behrsing, PhD, will be presenting at SIVB's Annual Meeting in St. Louis. His presentation on Tuesday, June 5th is titled "Pragmatic Use of State-of-the-Art Lung Models to Evaluate Exposure-induced, Adverse Pulmonary Effects" and will provide an overview of in vitro/ex vivo pulmonary models and how they can be incorporated into a screening/testing strategy for chemicals that can include more complex human pulmonary adverse events that are evaluable in modern 3D systems.
Read More...